Objective To update the 2009 Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) treatment recommendations for the spectrum of manifestations affecting …

… Author links open overlay panel Kristian Reich MD a , April W. Armstrong MD, MPH b , Peter
Foley MD c d , Michael Song MD e , Yasmine Wasfi MD, PhD e , Bruce Randazzo MD, PhD …

Importance Approximately 125 million people worldwide have psoriasis. Patients with
psoriasis experience substantial morbidity and increased rates of inflammatory arthritis, …

Background An urgent need exists in the United States to establish treatment goals in
psoriasis. Objective We aim to establish defined treatment targets toward which clinicians and …

Background Early clinical studies suggested that the anti–interleukin-17 receptor A monoclonal
antibody brodalumab has efficacy in the treatment of psoriasis. Methods In two phase 3 …

Background Psoriasis is a chronic inflammatory disorder associated with significant morbidity
and mortality. Up-to-date prevalence data on psoriasis provide the foundation for informing …

Psoriasis is a chronic, inflammatory multisystem disease that affects up to 3.2% of the US
population. This guideline addresses important clinical questions that arise in psoriasis …

Importance Determining psoriasis prevalence is fundamental to understanding the burden
of the disease, the populations most affected, and health policies to address the disease. …

Background Hidradenitis suppurativa is a painful, chronic inflammatory skin disease with
few options for effective treatment. In a phase 2 trial, adalimumab, an antibody against tumor …

BACKGROUND: Increasing population-based studies have suggested a relationship
between psoriasis and metabolic syndrome. OBJECTIVE: The objective of this study was to …